Business
Why the Mesoblast (ASX:MSB) share price rocketed 17% higher
The Mesoblast limited (ASX: MSB) share price was a very strong performer on Monday.
The biotech company’s shares finished the day a massive 17.5% higher at $4.28.
Why did the Mesoblast share price rocket higher?
Investors were buying the company’s shares again on Monday in response to a positive announcement at the end of last week.
That announcement revealed that the company has signed a major deal with pharma giant Novartis.
Novartis has signed an exclusive worldwide license and collaboration agreement for the development, manufacture, and commercialisation of Mesoblast’s mesenchymal stromal cell (MSC) product remestemcel-L.
The deal, which is focused on its treatment of COVID-19 Acute Respiratory Distress Syndrome (ARDS),…
-
Noosa News13 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General23 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Business22 hours agoRevenue growth, profit margin pressures, and a $365m buyback
-
Noosa News24 hours agoUrgent recall notice issued for deli meats over contamination risk